Cargando…
Vaccine‐induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report
BACKGROUND: Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a rare complication of the ChAdOx1 nCoV‐19 and Ad26.COV2.S COVID‐19 vaccines. It presents most commonly with severe thrombocytopenia and thrombotic complications with extremely high D‐dimer levels 5–30 days after vaccination. W...
Autores principales: | Lai, Chieh Min Benjamin, Lee, Agnes Y.Y., Parkin, Stephen B.I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115974/ https://www.ncbi.nlm.nih.gov/pubmed/35599706 http://dx.doi.org/10.1002/rth2.12716 |
Ejemplares similares
-
Prothrombotic immune thrombocytopenia after COVID-19 vaccination
por: Tiede, Andreas, et al.
Publicado: (2021) -
Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)
por: Thaler, Johannes, et al.
Publicado: (2021) -
Azd-1222: Prothrombotic immune thrombocytopenia: case report
Publicado: (2022) -
Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021) -
Aspirin/AZD-1222: Vaccine-induced prothrombotic immune thrombocytopenia: case report
Publicado: (2021)